Evidence map›Paper›PMID 40668101›Full record

ArticleThe Journal of infectious diseases2025

Post-Pandemic Dynamics of the Global Circulation of Human Metapneumovirus and Respiratory Syncytial Virus.

Marie-Noëlle Billard, Joanne G Wildenbeest, Ruben Kole, Barry Rodgers-Gray, John Fullarton, Louis Bont

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Twenty-five years of human metapneumovirus research.Clinical microbiology reviews · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marie-Noëlle BillardDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-0951-9744
Joanne G WildenbeestDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.
Ruben KoleDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.
Barry Rodgers-GrayViolicom Medical Limited, Aldermaston, United Kingdom.ORCID 0000-0003-0954-5587
John FullartonViolicom Medical Limited, Aldermaston, United Kingdom.ORCID 0000-0001-9429-5994
Louis BontDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.ORCID 0000-0003-3099-4475

Funding

AstraZeneca groupIcosavax, Inc
6 · The paper itself

Abstract

backgroundUnderstanding the seasonality of human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) is important for public health planning. It can support rationale for using another country data to model immunization strategies where seasonality data are lacking. While some studies have investigated (sub)-national seasonality drivers, this is the first to describe global seasonality for RSV and hMPV.

methodsWe included 26 countries with consistent reporting and >10 detections at the peak, after searching international databases and local reports. Weekly surveillance data from January 2022 to June 2024 were included. Viral activity was defined by comparing the 4-week moving average of the positivity rate to its annual average. "Seeding" events were the first 2 consecutive weeks with a statistically significant increase in detections.

resultsMost countries showed seasonal patterns of RSV and hMPV, except for some tropical countries. The RSV peak occurred systematically before the hMPV peak. On a Mercator projection, hMPV appeared to circulate in a counterclockwise manner, opposite to RSV. Although global information was incomplete, the first seeding events occurred in a short time in multiple countries with year-to-year variations.

conclusionsWe have provided critical information on the circulation of hMPV and RSV. We only found 26 countries reporting suitable surveillance data in publicly accessible reports, which likely reflects true gaps in surveillance.

Indexed as

MetapneumovirusParamyxoviridae InfectionsRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsDisease OutbreaksGlobal HealthHumansSeasonshMPVhuman metapneumovirusrespiratory syncytial virusseasonalitytransmission

Identifiers

PMID40668101
PMCPMC12265059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.